Abstract:Research detailing the normal vascular adaptions to high altitude is minimal and often confounded by pathology (e.g., chronic mountain sickness) and methodological issues. We examined vascular function and structure in: (1) healthy lowlanders during acute hypoxia and prolonged (∼2 weeks) exposure to high altitude, and (2) high-altitude natives at 5050 m (highlanders). In 12 healthy lowlanders (aged 32 ± 7 years) and 12 highlanders (Sherpa; 33 ± 14 years) we assessed brachial endothelium-dependent flow-mediated dilatation (FMD), endothelium-independent dilatation (via glyceryl trinitrate; GTN), common carotid intima-media thickness (CIMT) and diameter (ultrasound), and arterial stiffness via pulse wave velocity (PWV; applanation tonometry). Cephalic venous biomarkers of free radical-mediated lipid peroxidation (lipid hydroperoxides, LOOH), nitrite (NO2-) and lipid soluble antioxidants were also obtained at rest. In lowlanders, measurements were performed at sea level (334 m) and between days 3-4 (acute high altitude) and 12-14 (chronic high altitude) following arrival to 5050 m. Highlanders were assessed once at 5050 m. Compared with sea level, acute high altitude reduced lowlanders' FMD (7.9 ± 0.4 vs. 6.8 ± 0.4%; P = 0.004) and GTN-induced dilatation (16.6 ± 0.9 vs. 14.5 ± 0.8%; P = 0.006), and raised central PWV (6.0 ± 0.2 vs. 6.6 ± 0.3 m s(-1); P = 0.001). These changes persisted at days 12-14, and after allometrically scaling FMD to adjust for altered baseline diameter. Compared to lowlanders at sea level and high altitude, highlanders had a lower carotid wall:lumen ratio (∼19%, P ≤ 0.04), attributable to a narrower CIMT and wider lumen. Although both LOOH and NO2- increased with high altitude in lowlanders, only LOOH correlated with the reduction in GTN-induced dilatation evident during acute (n = 11, r = -0.53) and chronic (n = 7, r = -0.69; P ≤ 0.01) exposure to 5050 m. In a follow-up, placebo-controlled experiment (n = 11 healthy lowlanders) conducted in a normobaric hypoxic chamber (inspired O2 fraction (F IO 2) = 0.11; 6 h), a sustained reduction in FMD was evident within 1 h of hypoxic exposure when compared to normoxic baseline (5.7 ± 1.6 vs. 8.0 ±1.3%; P < 0.01); this decline in FMD was largely reversed following α1-adrenoreceptor blockade. In conclusion, high-altitude exposure in lowlanders caused persistent impairment in vascular function, which was mediated partially via oxidative stress and sympathoexcitation. Although a lifetime of high-altitude exposure neither intensifies nor attenuates the impairments seen with short-term exposure, chronic high-altitude exposure appears to be associated with arterial remodelling.

Divergent Mitochondrial Antioxidant Activities and Lung Alveolar Architecture in the Lungs of Rats and Mice at High Altitude

High Altitude Increases The Expression Of Hypoxia-Inducible Factor 1 Alpha And Inducible Nitric Oxide Synthase With Intest-Inal Mucosal Barrier Failure In Rats

Adaptive increases in respiratory capacity and O2 affinity of subsarcolemmal mitochondria from skeletal muscle of high‐altitude deer mice

Evolution and developmental plasticity of lung structure in high-altitude deer mice

Evaluation of blood cellular and biochemical parameters in rats under a chronic hypoxic environment at high altitude

Inactivation Of Corticotropin-Releasing Hormone-Induced Insulinotropic Role By High-Altitude Hypoxia

Effect of Acute and Chronic Exposure to High Altitude on the Aerobic and Anaerobic Metabolism in Rats.

A global view on quantitative proteomic and metabolic analysis of rat livers under different hypoxia protocols

Telomeres are elongated in rats exposed to moderate altitude

Oxidative stress and expression of inflammatory factors in lung tissue of acute mountain sickness rats

The Effects of a Graded Increase in Chronic Hypoxia Exposure Duration on Healthy Rats at High-Altitude

Conduit artery structure and function in lowlanders and native highlanders: relationships with oxidative stress and role of sympathoexcitation

Modification of Intestinal Flora Can Improve Host Metabolism and Alleviate the Damage Caused by Chronic Hypoxia

Blunted hypoxic pulmonary vasoconstrictive response in the rodent <i>Ochotona curzoniae</i> (pika) at high altitude

Astaxanthin Supplementation Effects in Right Ventricle of Rats Exposed to Chronic Intermittent Hypobaric Hypoxia

Body growth, lung and heart weight, and DNA content in newborn rats exposed to different levels of chronic hypoxia

Mitochondrial function in lungs of rats with different susceptibilities to hyperoxia-induced Acute Lung Injury

Resveratrol Ameliorates Chronic High Altitude Exposure‐induced Oxidative Stress and Suppresses Lipid Metabolism Alteration in Rats

Evolved changes in phenotype across skeletal muscles in deer mice native to high altitude

Development of aptitude at altitude

Lung function and blood gas of rats after different protocols of hypobaric exposure